Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Abbvie Inc (NYSE: ABBV) closed the day trading at $176.17 down -0.16% from the previous closing price of $176.46. In other words, the price has decreased by -$0.16 from its previous closing price. On the day, 5.44 million shares were traded. ABBV stock price reached its highest trading level at $176.72 during the session, while it also had its lowest trading level at $173.58.
Ratios:
For a better understanding of ABBV, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.98. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 0.65. In the meantime, Its Debt-to-Equity ratio is 11.78 whereas as Long-Term Debt/Eq ratio is at 9.70.
On November 22, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform but kept the price unchanged to $206.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $205.Wolfe Research initiated its Outperform rating on November 15, 2024, with a $205 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when Hudson Thomas J bought 49,170 shares for $189.08 per share.
GONZALEZ RICHARD A sold 66,500 shares of ABBV for $12,403,580 on Aug 05 ’24. The EXECUTIVE CHAIRMAN OF BOARD now owns 446,599 shares after completing the transaction at $186.52 per share. On Aug 07 ’24, another insider, Hudson Thomas J, who serves as the Officer of the company, bought 101,886 shares for $187.62 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABBV now has a Market Capitalization of 311829725184 and an Enterprise Value of 375394107392. As of this moment, Abbvie’s Price-to-Earnings (P/E) ratio for their current fiscal year is 61.44, and their Forward P/E ratio for the next fiscal year is 14.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.61 while its Price-to-Book (P/B) ratio in mrq is 51.61. Its current Enterprise Value per Revenue stands at 6.76 whereas that against EBITDA is 14.647.
Stock Price History:
Over the past 52 weeks, ABBV has reached a high of $207.32, while it has fallen to a 52-week low of $142.66. The 50-Day Moving Average of the stock is -5.94%, while the 200-Day Moving Average is calculated to be -1.62%.
Shares Statistics:
Over the past 3-months, ABBV traded about 5.80M shares per day on average, while over the past 10 days, ABBV traded about 6687630 shares per day. A total of 1.77B shares are outstanding, with a floating share count of 1.77B. Insiders hold about 0.08% of the company’s shares, while institutions hold 72.95% stake in the company. Shares short for ABBV as of 1731628800 were 20169830 with a Short Ratio of 3.47, compared to 1728950400 on 16183592. Therefore, it implies a Short% of Shares Outstanding of 20169830 and a Short% of Float of 1.1400000000000001.
Dividends & Splits
ABBV’s forward annual dividend rate is 6.20, up from 6.2 a year ago. Against a Trailing Annual Dividend Yield of 0.03513544The stock’s 5-year Average Dividend Yield is 4.13.
